A Decision Framework For The Access Strategy Of Medicines For Malaria Venture
Many new Product Development Partnerships (PDPs) have recently been formed with the sole objective of developing drugs for neglected diseases with a high prevalence in the developing world. A medicine for Malaria Venture (MMV) is a PDP that was established in 1999 to develop new effective drugs for malaria. With an initial mission to "discover" and "develop" drugs, in 2006, MMV took on the additional challenge of "delivery" of its products. This paper identifies the main issues to be addressed in order to ensure the uptake of anti-malarial drugs and examines MMV's role as a public private partnership in tackling these issues.